Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
CR-CP Life Science Fund is a venture capital fund jointly sponsored by China Resources Group and Charoen Pokphand Group. The fund invests in leading life science companies that develop innovative drugs, cell therapies, medical devices, and smart healthcare technologies. Its main goal is to support and promote advancements in the field of life sciences, with a particular emphasis on improving healthcare outcomes and patient well-being. The fund has a global investment approach, including investments in Israeli companies.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is CR-CP Life Science Fund's primary investment focus?
- CR-CP Life Science Fund primarily invests in the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this category.
- Can you name some of CR-CP Life Science Fund's notable portfolio companies?
- CR-CP Life Science Fund's portfolio includes BELKIN Vision, which develops one-second laser treatments for glaucoma.
- Has CR-CP Life Science Fund had any recent exits?
- Yes, CR-CP Life Science Fund had an exit in July 2024 when BELKIN Vision was acquired by Alcon Pharmaceuticals for $81M.
- What is CR-CP Life Science Fund's typical investment stage?
- CR-CP Life Science Fund has participated in B Round and C Round investments, with one investment in each stage.
- When did CR-CP Life Science Fund make its most recent portfolio investments?
- CR-CP Life Science Fund made new portfolio investments in July 2020 and March 2021.
- What is the investment range for CR-CP Life Science Fund?
- CR-CP Life Science Fund's investment range is between $12.25M and $25M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2019-1 |
|---|